2020
DOI: 10.1007/s10072-020-04879-4
|View full text |Cite
|
Sign up to set email alerts
|

Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles